To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene STX6TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
374 supporting clones for gene STX6 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
CR609438 B cells (Ramos cell line) Cot 25-normalized .a 1 to 1536 1 to 1536 exact tiling clone,   1536/1536
(100 %)
0 diff
(100 %id)
CR608098 Neuroblastoma Cot 25-normalized .a 5 to 1839 1 to 1835 exact tiling clone,   1835/1835
(100 %)
0 diff
(100 %id)
CR610805 Placenta Cot 25-normalized .a 9 to 1558 1 to 1550 exact     1550/1550
(100 %)
0 diff
(100 %id)
CR591752 Neuroblastoma Cot 25-normalized .b 1 to 1385 1 to 1385 exact tiling clone,   1385/1385
(100 %)
0 diff
(100 %id)
AK056657 brain .b 1084 to 3510 1 to 2427   tiling clone, available from FLJ,   2427/2427
(100 %)
6 diff
(99.8 %id)
DA768797 brain .b 1085 to 1550 2 to 467   capped   466/466
(100 %)
0 diff
(100 %id)
DB177806 kidney, tumor tissue .b 1754 to 2310 2 to 554   tiling clone, capped   553/553
(100 %)
2 diff
(99.7 %id)
DW424328 Liver .b 2333 to 2606 17 to 289       273/289
(94 %)
6 diff
(98.0 %id)
DB325605 brain .b 2967 to 3510 544 to 1       544/544
(100 %)
2 diff
(99.7 %id)
AI884934 anaplastic oligodendroglioma, brain .b 2969 to 3504 536 to 1       536/536
(100 %)
3 diff
(99.5 %id)
AI566581 anaplastic oligodendroglioma, brain .b 3130 to 3503 374 to 1       374/374
(100 %)
3 diff
(99.2 %id)
AW291565   .b 3162 to 3503 359 to 18   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 342/342
(100 %)
1 diff
(99.8 %id)
DA311923 hippocampus .c 1 to 534 2 to 536   tiling clone, capped   535/535
(100 %)
2 diff
(99.7 %id)
DA498976 brain .c 110 to 667 2 to 559   capped   558/558
(100 %)
2 diff
(99.7 %id)
DB148238 thymus .c 194 to 757 2 to 567   capped   566/566
(100 %)
2 diff
(99.7 %id)
DA802373 brain .c 205 to 778 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DA038227   .c 208 to 772 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
BG332647 large cell carcinoma, lung .c 210 to 955 1 to 745       745/945
(78 %)
34 diff
(96.5 %id)
BU902578 leiomyosarcoma, uterus .c 210 to 1049 1 to 843       843/913
(92 %)
16 diff
(98.3 %id)
NM_005819.4   .c 211 to 4727 1 to 4517 exact RefSeq, AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 4517/4517
(100 %)
1 diff
(100.0 %id)
AK312440 brain .c 214 to 1215 1 to 1003 exact     1003/1003
(100 %)
2 diff
(99.9 %id)
DA242744 brain .c 215 to 800 2 to 588   capped   587/587
(100 %)
1 diff
(99.9 %id)
DA746229   .c 217 to 772 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DA457319 tongue, tumor tissue .c 218 to 788 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
AL527857 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .c 220 to 778 1 to 559   fully sequenced,   559/559
(100 %)
1 diff
(99.9 %id)
TI_154186129   .c 220 to 1034 121 to 928       808/984
(82 %)
10 diff
(99.0 %id)
DN990778 brain, whole brain .c 225 to 878 1 to 654       654/654
(100 %)
4 diff
(99.4 %id)
BI917353 brain .c 226 to 879 1 to 654       654/654
(100 %)
0 diff
(100 %id)
TI_57244643   .c 226 to 879 32 to 685       654/685
(95 %)
6 diff
(99.2 %id)
BG256961 embryonal carcinoma, cell line, testis .c 227 to 912 1 to 703       703/1035
(67 %)
37 diff
(96.5 %id)
AU128288   .c 227 to 755 2 to 531   capped   530/531
(99 %)
7 diff
(98.7 %id)
DB220147 trachea .c 228 to 786 2 to 565   capped   564/564
(100 %)
6 diff
(99.0 %id)
BX280773 brain .c 229 to 713 1 to 485       485/485
(100 %)
0 diff
(100 %id)
AL560849 B cells from Burkitt lymphoma .c 230 to 1005 1 to 777   fully sequenced,   777/777
(100 %)
3 diff
(99.7 %id)
DA174736 amygdala .c 232 to 766 2 to 537   capped   536/536
(100 %)
1 diff
(99.9 %id)
AL526444 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .c 234 to 1218 1 to 983 T229X I238X L241X V248X L249X ... fully sequenced,   983/983
(100 %)
5 diff
(99.5 %id)
AL545354 placenta, Placenta Cot 25-normalized .c 238 to 1074 1 to 837   fully sequenced,   837/837
(100 %)
1 diff
(99.9 %id)
CF137125 lymph .c 242 to 652 8 to 418       411/419
(98 %)
10 diff
(97.7 %id)
TI_154166500   .c 242 to 809 90 to 657       568/934
(60 %)
3 diff
(99.7 %id)
DA515281 brain .c 250 to 797 2 to 549   capped   548/548
(100 %)
2 diff
(99.7 %id)
DC333951 hippocampus .c 251 to 512 1 to 262       262/262
(100 %)
0 diff
(100 %id)
BP214994 corpus callosum .c 251 to 834 1 to 584       584/584
(100 %)
6 diff
(99.0 %id)
BP278997   .c 252 to 838 1 to 587       587/587
(100 %)
0 diff
(100 %id)
BP298275   .c 252 to 825 1 to 574       574/574
(100 %)
0 diff
(100 %id)
DA023633   .c 253 to 810 2 to 559   capped   558/558
(100 %)
1 diff
(99.9 %id)
DA038018   .c 253 to 809 2 to 559   capped   558/558
(100 %)
2 diff
(99.7 %id)
DA153271 amygdala .c 253 to 821 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA298933 hippocampus .c 253 to 830 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
DA375873 thalamus .c 253 to 801 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
DA557131   .c 253 to 798 2 to 547   capped   546/546
(100 %)
1 diff
(99.9 %id)
DA727134   .c 253 to 813 2 to 562   capped   561/561
(100 %)
1 diff
(99.9 %id)
DA836637 placenta .c 253 to 652 2 to 402   capped   401/401
(100 %)
1 diff
(99.8 %id)
DA322579 hippocampus .c 255 to 807 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
DA440762 tongue, tumor tissue .c 255 to 806 2 to 554   capped   553/553
(100 %)
1 diff
(99.9 %id)
DA110482 cerebellum .c 261 to 831 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DB202401 trachea .c 261 to 835 2 to 576   capped   575/575
(100 %)
1 diff
(99.9 %id)
BX419935 brain, fetal brain .c 263 to 1138 24 to 899       876/899
(97 %)
43 diff
(95.3 %id)
BX463993 brain, fetal brain .c 263 to 1269 22 to 1022 L245C L246W V247X V248C L249S ...     1001/1028
(97 %)
12 diff
(98.9 %id)
DA702059   .c 265 to 789 2 to 526   capped   525/525
(100 %)
0 diff
(100 %id)
CR995224 T-Lymphocytes .c 275 to 1134 1 to 863       863/863
(100 %)
5 diff
(99.5 %id)
BF304875 muscle, rhabdomyosarcoma .c 276 to 1040 1 to 767       767/798
(96 %)
26 diff
(96.8 %id)
BC009944 Muscle, rhabdomyosarcoma .c 277 to 1817 1 to 1541 exact tiling clone, available from MGC, AAA   1541/1541
(100 %)
0 diff
(100 %id)
BU179596 large cell carcinoma, lung .c 279 to 1130 1 to 866       866/917
(94 %)
25 diff
(97.3 %id)
BF973273 leiomyosarcoma cell line, uterus .c 280 to 936 1 to 662       662/901
(73 %)
14 diff
(98.5 %id)
CN293561 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 281 to 797 1 to 517       517/517
(100 %)
3 diff
(99.5 %id)
BX332008 Neuroblastoma Cot 25-normalized .c 286 to 1138 1 to 852       852/852
(100 %)
2 diff
(99.8 %id)
BQ954021 leiomyosarcoma, uterus .c 286 to 1049 1 to 763       763/1013
(75 %)
11 diff
(99.0 %id)
CN293562 embryonic stem cells, cell lines H1, H7, andH9 .c 287 to 1027 1 to 741       741/741
(100 %)
3 diff
(99.6 %id)
AL556927 placenta .c 289 to 1216 1 to 928 exact     928/928
(100 %)
0 diff
(100 %id)
BE893126 melanotic melanoma, skin .c 294 to 1039 1 to 748       748/863
(86 %)
11 diff
(98.8 %id)
AL528699 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .c 296 to 1138 1 to 843       843/843
(100 %)
4 diff
(99.6 %id)
BG827385 muscle, rhabdomyosarcoma .c 430 to 1008 174 to 762       684/764
(89 %)
30 diff
(96.1 %id)
BX488314   .c 435 to 985 1 to 551       551/551
(100 %)
3 diff
(99.5 %id)
BE712464 head_neck .c 437 to 936 1 to 505       505/513
(98 %)
26 diff
(95.0 %id)
TI_1948101892   .c 447 to 841 127 to 521   fully sequenced,   395/521
(75 %)
9 diff
(98.3 %id)
TI_1948102060   .c 447 to 778 126 to 457   fully sequenced,   332/457
(72 %)
0 diff
(100 %id)
TI_1948102213   .c 447 to 967 129 to 650   fully sequenced,   522/650
(80 %)
7 diff
(99.0 %id)
AJ002078   .c 448 to 1215 1 to 768 exact     768/768
(100 %)
1 diff
(99.9 %id)
CR541856   .c 448 to 1215 1 to 768 exact     768/768
(100 %)
2 diff
(99.8 %id)
CR541873   .c 448 to 1212 1 to 765       765/765
(100 %)
3 diff
(99.7 %id)
CV027866 mixed .c 448 to 1058 1 to 611       611/611
(100 %)
0 diff
(100 %id)
TI_1948101556   .c 448 to 778 127 to 457   fully sequenced,   331/457
(72 %)
6 diff
(98.7 %id)
TI_1948101722   .c 453 to 841 132 to 521   fully sequenced,   390/521
(74 %)
6 diff
(98.9 %id)
DB465033 hippocampus .c 454 to 898 1 to 446       446/446
(100 %)
3 diff
(99.4 %id)
AI339089 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 474 to 797 324 to 1       324/331
(97 %)
0 diff
(100 %id)
BF918123 uterus_tumor .c 511 to 811 1 to 301       301/353
(85 %)
2 diff
(99.5 %id)
DA335598 hippocampus .c 678 to 1271 2 to 595   capped   594/594
(100 %)
2 diff
(99.7 %id)
BP352175   .c 693 to 1269 1 to 580       580/582
(99 %)
5 diff
(99.2 %id)
AL562997 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .c 717 to 1604 887 to 1   fully sequenced,   887/887
(100 %)
7 diff
(99.3 %id)
TI_1948101557   .c 717 to 1214 620 to 123   fully sequenced,   498/620
(80 %)
0 diff
(100 %id)
TI_1948102061   .c 717 to 1214 622 to 125   fully sequenced,   498/622
(80 %)
2 diff
(99.7 %id)
BQ671607 epidermoid carcinoma, cell line, salivary gland .c 743 to 1668 1 to 938       938/999
(93 %)
42 diff
(95.8 %id)
AA337908 endometrium .c 745 to 1013 1 to 269       269/269
(100 %)
0 diff
(100 %id)
DA324569 hippocampus .c 747 to 1106 110 to 469   capped   360/468
(76 %)
6 diff
(98.8 %id)
TI_1948101723   .c 780 to 1214 578 to 142   fully sequenced,   437/578
(75 %)
2 diff
(99.7 %id)
TI_1948101893   .c 780 to 1221 558 to 116   fully sequenced,   443/558
(79 %)
2 diff
(99.7 %id)
BF813957 colon_ins .c 795 to 1220 1 to 426       426/426
(100 %)
1 diff
(99.8 %id)
BM450161 melanotic melanoma, skin .c 873 to 1400 1 to 529       529/1355
(39 %)
8 diff
(99.5 %id)
TI_1948102214   .c 906 to 1214 370 to 62   fully sequenced,   309/336
(91 %)
0 diff
(100 %id)
BX955915   .c 917 to 1424 1 to 508       508/508
(100 %)
2 diff
(99.7 %id)
AW843854 colon_normal .c 930 to 1177 249 to 1       249/250
(99 %)
8 diff
(96.8 %id)
AW844046 colon_normal .c 930 to 1193 11 to 274       268/277
(96 %)
13 diff
(95.4 %id)
BF900779 marrow .c 931 to 1325 14 to 406       397/406
(97 %)
9 diff
(97.8 %id)
CF135675 lymph .c 946 to 1539 1 to 594       594/594
(100 %)
5 diff
(99.2 %id)
TI_154164172   .c 953 to 1730 69 to 842       774/905
(85 %)
14 diff
(98.5 %id)
BF105135 Kidney .c 964 to 1595 1 to 629       629/630
(99 %)
20 diff
(96.9 %id)
AL582196 B cells from Burkitt lymphoma .c 975 to 1765 791 to 1   fully sequenced,   791/791
(100 %)
1 diff
(99.9 %id)
BQ301509 bocio_tumor .c 983 to 1210 254 to 28       227/254
(89 %)
1 diff
(99.7 %id)
BM711473 eye, fetal eyes .c 985 to 1519 1 to 535       535/535
(100 %)
3 diff
(99.5 %id)
AL571114 placenta, Placenta Cot 25-normalized .c 1013 to 1784 782 to 4   fully sequenced,   779/782
(99 %)
1 diff
(99.9 %id)
BX475062   .c 1046 to 1611 1 to 566       566/566
(100 %)
8 diff
(98.6 %id)
BX475069   .c 1046 to 1573 1 to 528       528/528
(100 %)
0 diff
(100 %id)
TI_227714409   .c 1067 to 1798 824 to 93   AAA   732/962
(76 %)
13 diff
(98.7 %id)
BX283398 adenocarcinoma cell line, colon .c 1123 to 1629 1 to 507       507/507
(100 %)
1 diff
(99.9 %id)
BG468353 adenocarcinoma cell line, colon .c 1123 to 1868 1 to 743       743/897
(82 %)
21 diff
(97.7 %id)
CA427338 Cell Line, Chondrosarcoma .c 1140 to 1805 686 to 19   AAA   668/668
(100 %)
4 diff
(99.5 %id)
BI914492 brain .c 1167 to 1821 30 to 692       663/705
(94 %)
24 diff
(96.6 %id)
TI_57242918   .c 1167 to 1821 60 to 722       663/735
(90 %)
24 diff
(96.8 %id)
AL526403 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .c 1188 to 2068 877 to 1   fully sequenced,   877/877
(100 %)
3 diff
(99.7 %id)
CR612118 Neuroblastoma Cot 10-normalized .c 1192 to 1792 1 to 601       601/601
(100 %)
0 diff
(100 %id)
BX344777 Neuroblastoma Cot 10-normalized .c 1192 to 1805 1 to 614       614/614
(100 %)
0 diff
(100 %id)
BX352742 Neuroblastoma Cot 10-normalized .c 1192 to 1805 1 to 614       614/614
(100 %)
0 diff
(100 %id)
BX403067 Neuroblastoma Cot 10-normalized .c 1192 to 1757 575 to 10       566/575
(98 %)
2 diff
(99.7 %id)
CD365180 Alveolar Macrophage, lung .c 1212 to 1798 603 to 17   AAA   587/587
(100 %)
3 diff
(99.5 %id)
BF089103 head_neck .c 1238 to 1495 1 to 258       258/258
(100 %)
1 diff
(99.7 %id)
Z42051 brain, total brain .c 1270 to 1518 1 to 249       249/249
(100 %)
0 diff
(100 %id)
BU429568 lymph .c 1273 to 1774 8 to 509       502/509
(98 %)
6 diff
(98.9 %id)
TI_154150692   .c 1273 to 2074 81 to 880       800/802
(99 %)
40 diff
(95.1 %id)
BY994720   .c 1303 to 1968 10 to 675       666/675
(98 %)
6 diff
(99.2 %id)
BF900769 marrow .c 1311 to 1557 252 to 8     Submitted on the opposite strand 245/260
(94 %)
0 diff
(100 %id)
DA989013 synovial membrane tissue from rheumatioidarthritis .c 1311 to 1859 2 to 550   capped   549/549
(100 %)
1 diff
(99.9 %id)
N52259 multiple sclerosis lesions .c 1319 to 1806 492 to 1       492/499
(98 %)
4 diff
(99.2 %id)
BG391820 embryonal carcinoma, cell line, testis .c 1319 to 1805 1 to 491   AAA   491/491
(100 %)
5 diff
(99.0 %id)
AI083723 anaplastic oligodendroglioma, brain .c 1341 to 1798 458 to 1       458/458
(100 %)
0 diff
(100 %id)
AI144442 heart .c 1356 to 1818 463 to 1       463/463
(100 %)
0 diff
(100 %id)
AI090548 heart .c 1368 to 1799 432 to 1       432/432
(100 %)
0 diff
(100 %id)
BE893304 melanotic melanoma, skin .c 1373 to 2104 1 to 738       738/740
(99 %)
11 diff
(98.6 %id)
BQ688781 ductal carcinoma, cell line, Pancreas .c 1401 to 2184 1 to 789       789/908
(86 %)
7 diff
(99.3 %id)
CN483917 eye .c 1405 to 2029 1 to 625       625/625
(100 %)
0 diff
(100 %id)
AI400727 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 1426 to 1798 372 to 1       372/372
(100 %)
1 diff
(99.8 %id)
AW043915 pooled .c 1448 to 1798 361 to 11   AAA   351/351
(100 %)
0 diff
(100 %id)
BX352741 Neuroblastoma Cot 10-normalized .c 1635 to 1769 156 to 22       531/599
(88 %)
18 diff
(97.0 %id)
DA491333 brain .c 1654 to 2221 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
AI909691 breast .c 1656 to 2453 794 to 1       794/798
(99 %)
53 diff
(93.4 %id)
DA787136 brain .c 1688 to 2212 2 to 527   capped   526/530
(99 %)
3 diff
(99.5 %id)
DB129624 thymus .c 1715 to 2255 2 to 542   tiling clone, capped   541/541
(100 %)
1 diff
(99.9 %id)
AL579038 placenta .c 1821 to 2786 969 to 1       969/988
(98 %)
40 diff
(96.0 %id)
CX868191 embryonic stem .c 1835 to 2465 1 to 633     Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 633/633
(100 %)
6 diff
(99.1 %id)
TI_149310058   .c 1844 to 2821 1057 to 92   AAA   966/974
(99 %)
24 diff
(97.6 %id)
DA170463 amygdala .c 1883 to 2408 2 to 528   capped   527/527
(100 %)
1 diff
(99.9 %id)
DA786075 brain .c 1921 to 2500 2 to 584   capped   583/583
(100 %)
2 diff
(99.7 %id)
TI_149308971   .c 1964 to 2820 940 to 92   AAA   849/953
(89 %)
12 diff
(98.8 %id)
DA526663 brain .c 1992 to 2553 2 to 565   capped   564/564
(100 %)
1 diff
(99.9 %id)
DA444210 tongue, tumor tissue .c 1993 to 2545 2 to 558   capped   557/557
(100 %)
5 diff
(99.2 %id)
BF832532 head_neck .c 2025 to 2404 1 to 374       374/374
(100 %)
7 diff
(98.2 %id)
BY996233   .c 2045 to 2672 21 to 648       628/648
(96 %)
6 diff
(99.1 %id)
TI_154115947   .c 2047 to 2821 872 to 100   AAA   773/791
(97 %)
30 diff
(96.3 %id)
AI073357 senescent fibroblast .c 2072 to 2525 465 to 12   AAA   454/454
(100 %)
0 diff
(100 %id)
BU688313 lung .c 2078 to 2821 763 to 19   AAA   745/745
(100 %)
4 diff
(99.5 %id)
BU687412 lung .c 2111 to 2820 728 to 19   AAA   710/710
(100 %)
0 diff
(100 %id)
DA519685 brain .c 2120 to 2686 2 to 572   capped   571/571
(100 %)
3 diff
(99.5 %id)
TI_151717686   .c 2123 to 2826 824 to 116       709/876
(80 %)
0 diff
(100 %id)
BF035815 adenocarcinoma, ovary .c 2124 to 2819 1 to 693       693/814
(85 %)
12 diff
(98.6 %id)
BU853515 testis .c 2169 to 2867 1 to 709       709/832
(85 %)
9 diff
(99.0 %id)
DB141017 thymus .c 2185 to 2690 2 to 509   capped   508/508
(100 %)
1 diff
(99.9 %id)
DA263555 caudate nucleus .c 2190 to 2745 2 to 559   capped   558/558
(100 %)
1 diff
(99.9 %id)
H42139 breast .c 2225 to 2734 1 to 516       516/520
(99 %)
17 diff
(96.8 %id)
BM551560 melanotic melanoma, skin .c 2227 to 3118 25 to 927   tiling clone,   903/1076
(83 %)
20 diff
(98.2 %id)
BX456866 thymus .c 2248 to 3106 1 to 854       854/859
(99 %)
16 diff
(98.2 %id)
BU626097 cell lines, Enchondroma .c 2252 to 2824 593 to 19   AAA   575/575
(100 %)
1 diff
(99.9 %id)
CA449492 Chondrosarcoma, Left Pelvis .c 2258 to 2821 583 to 19   AAA   565/565
(100 %)
2 diff
(99.7 %id)
DB365452   .c 2261 to 2817 557 to 1       557/575
(96 %)
6 diff
(99.0 %id)
BG121084 adenocarcinoma, cell line, Liver .c 2267 to 2817 1 to 541   AAA   541/541
(100 %)
11 diff
(98.0 %id)
AI740832 pooled .c 2274 to 2829 557 to 1       557/557
(100 %)
2 diff
(99.7 %id)
AI627735 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .c 2289 to 2817 532 to 3       530/532
(99 %)
0 diff
(100 %id)
BF057223 pooled germ cell tumors .c 2306 to 2817 513 to 2       512/513
(99 %)
0 diff
(100 %id)
AW270898 Kidney .c 2308 to 2819 514 to 1       514/514
(100 %)
2 diff
(99.7 %id)
BI094484 cervix .c 2319 to 2820 1 to 504       504/663
(76 %)
8 diff
(98.8 %id)
DA792660 brain .c 2356 to 2975 2 to 624   capped   623/623
(100 %)
4 diff
(99.4 %id)
AI358490 adenocarcinoma, Pancreas .c 2358 to 2822 468 to 1       468/468
(100 %)
2 diff
(99.6 %id)
DA954634 Spleen .c 2362 to 2898 2 to 538   capped   537/537
(100 %)
0 diff
(100 %id)
DA734178   .c 2367 to 2985 2 to 629   capped   628/668
(94 %)
11 diff
(98.4 %id)
DB121803 thymus .c 2368 to 2906 2 to 543   capped   542/542
(100 %)
2 diff
(99.7 %id)
BM013610 breast, mammary adenocarcinoma, cell line .c 2371 to 3108 1 to 736       736/736
(100 %)
2 diff
(99.8 %id)
TI_59391513   .c 2371 to 3108 55 to 790       736/736
(100 %)
2 diff
(99.8 %id)
AI142729 pooled .c 2373 to 2826 457 to 4       454/457
(99 %)
0 diff
(100 %id)
BF513194   .c 2377 to 2824 462 to 15   AAA   448/448
(100 %)
0 diff
(100 %id)
DA611356   .c 2379 to 2816 2 to 440   capped   439/439
(100 %)
2 diff
(99.6 %id)
DA306581 hippocampus .c 2380 to 2952 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
AW008580 brain, glioblastoma (pooled) .c 2423 to 2813 391 to 1       391/391
(100 %)
0 diff
(100 %id)
DB258126 uterus .c 2425 to 3015 2 to 592   capped   591/591
(100 %)
1 diff
(99.9 %id)
DA730979   .c 2427 to 3123 2 to 699   capped   698/698
(100 %)
2 diff
(99.8 %id)
DA492404 brain .c 2432 to 2996 2 to 566   capped   565/565
(100 %)
2 diff
(99.7 %id)
DA550834   .c 2432 to 3269 2 to 834   capped   833/833
(100 %)
12 diff
(98.6 %id)
DA557066   .c 2435 to 3005 2 to 573   capped   572/572
(100 %)
2 diff
(99.7 %id)
BF431929 pooled .c 2435 to 2829 396 to 1       396/396
(100 %)
21 diff
(94.7 %id)
AA975205 Kidney .c 2439 to 2817 379 to 1       379/379
(100 %)
0 diff
(100 %id)
AW078976 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .c 2450 to 2817 369 to 2       368/369
(99 %)
0 diff
(100 %id)
GD161070   .c 2460 to 2525 1 to 66   AAA   66/66
(100 %)
6 diff
(91.0 %id)
DA161598 amygdala .c 2515 to 3072 2 to 560   capped   559/560
(99 %)
3 diff
(99.5 %id)
AI952852 pooled germ cell tumors .c 2553 to 2817 266 to 2       265/266
(99 %)
0 diff
(100 %id)
AI122930 pooled .c 2557 to 2829 273 to 1       273/273
(100 %)
1 diff
(99.7 %id)
DA349932 substantia nigra .c 2574 to 3137 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DA310006 hippocampus .c 2575 to 3149 2 to 577   capped   576/576
(100 %)
2 diff
(99.7 %id)
DA155816 amygdala .c 2582 to 3149 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
AW188205 pooled .c 2594 to 3115 537 to 17   AAA   521/521
(100 %)
2 diff
(99.7 %id)
AI864351 pooled .c 2605 to 2829 226 to 1       226/226
(100 %)
1 diff
(99.6 %id)
DA692713   .c 2607 to 3178 2 to 576   capped   575/579
(99 %)
4 diff
(99.4 %id)
AI270067 colon, moderately-differentiated adenocarcinoma .c 2610 to 2813 230 to 29   AAA   202/204
(99 %)
5 diff
(97.6 %id)
DB109366 thymus .c 2612 to 3180 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
Z38335 brain, total brain .c 2654 to 2817 164 to 1       164/175
(93 %)
1 diff
(99.5 %id)
CB218372 mandible, pooled .c 2667 to 3202 21 to 554     Submitted on the opposite strand 534/554
(96 %)
6 diff
(99.0 %id)
CB218373 mandible, pooled .c 2667 to 3202 534 to 1     Submitted on the opposite strand 534/554
(96 %)
7 diff
(98.8 %id)
DA690820   .c 2668 to 3244 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
BF002269 colon, colon tumor, RER+ .c 2679 to 3120 454 to 13   AAA   442/442
(100 %)
2 diff
(99.6 %id)
T24469   .c 2683 to 2822 142 to 3       140/142
(98 %)
0 diff
(100 %id)
DA447331 tongue, tumor tissue .c 2692 to 3274 2 to 584   capped   583/583
(100 %)
0 diff
(100 %id)
AI952613 normal epithelium, ovary .c 2694 to 3120 428 to 1       428/428
(100 %)
1 diff
(99.8 %id)
F12711 brain, total brain .c 2713 to 2983 1 to 252       252/252
(100 %)
17 diff
(93.3 %id)
T75195 whole brain .c 2733 to 3226 1 to 499     Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 499/499
(100 %)
10 diff
(98.0 %id)
AA331328 Embryo, 8 weeks .c 2751 to 2965 1 to 215       215/215
(100 %)
0 diff
(100 %id)
DB123312 thymus .c 2819 to 3343 2 to 526   capped   525/525
(100 %)
1 diff
(99.9 %id)
DA085908 cerebellum .c 2822 to 3355 2 to 536   capped   535/535
(100 %)
2 diff
(99.7 %id)
AU124682   .c 2831 to 3679 2 to 847   capped   846/846
(100 %)
11 diff
(98.7 %id)
BU660697 blood .c 2851 to 3352 11 to 512       502/512
(98 %)
6 diff
(98.9 %id)
BU928945 brain, glioblastoma .c 2852 to 3720 1 to 873   tiling clone,   873/874
(99 %)
10 diff
(98.9 %id)
DA829276 placenta .c 2875 to 3776 2 to 915   capped   914/919
(99 %)
23 diff
(97.5 %id)
Z43300 brain, total brain .c 2881 to 3066 1 to 186       186/186
(100 %)
1 diff
(99.5 %id)
R52889 whole brain .c 2882 to 3282 1 to 404       404/411
(98 %)
5 diff
(98.8 %id)
F13155 brain, total brain .c 2896 to 3249 1 to 354       354/354
(100 %)
0 diff
(100 %id)
T75458 whole brain .c 2899 to 3347 1 to 458       458/466
(98 %)
21 diff
(95.5 %id)
BG260855 bladder, transitional cell papilloma, cell line .c 2948 to 3653 1 to 695       695/963
(72 %)
13 diff
(98.7 %id)
AL589380 human spinal cord .c 2949 to 3406 20 to 477       458/477
(96 %)
6 diff
(98.8 %id)
DB041971 testis .c 2956 to 3526 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
AF038202 brain .c 3015 to 4756 1 to 1742   tiling clone, AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 1742/1742
(100 %)
1 diff
(100.0 %id)
F13279 brain, total brain .c 3015 to 3366 1 to 352       352/352
(100 %)
0 diff
(100 %id)
T77306 whole brain .c 3041 to 3410 1 to 382     Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 382/386
(98 %)
16 diff
(95.9 %id)
CR744580   .c 3063 to 3791 1 to 729       729/729
(100 %)
0 diff
(100 %id)
T78171 liver and spleen .c 3078 to 3527 1 to 464       464/464
(100 %)
25 diff
(94.7 %id)
BG117770 adenocarcinoma, cell line, Liver .c 3110 to 3845 1 to 733       733/982
(74 %)
16 diff
(98.4 %id)
AA337478 endometrium .c 3126 to 3407 1 to 282       282/282
(100 %)
6 diff
(97.9 %id)
AW960786   .c 3127 to 3826 1 to 700       700/700
(100 %)
2 diff
(99.8 %id)
BG260404 bladder, transitional cell papilloma, cell line .c 3153 to 3946 1 to 793       793/948
(83 %)
16 diff
(98.4 %id)
Z44267 brain, total brain .c 3176 to 3504 1 to 329       329/329
(100 %)
2 diff
(99.4 %id)
TI_57230872   .c 3207 to 3919 48 to 761       714/715
(99 %)
4 diff
(99.5 %id)
BI870396 adenocarcinoma, cell line, Liver .c 3208 to 3919 1 to 713       713/714
(99 %)
4 diff
(99.5 %id)
DN601564 human embryonic stem cells .c 3209 to 3994 1 to 787       787/787
(100 %)
3 diff
(99.7 %id)
BQ420812 embryonal carcinoma, cell line, testis .c 3220 to 4077 1 to 861       861/861
(100 %)
10 diff
(98.9 %id)
BF216014 brain, glioblastoma .c 3236 to 3845 1 to 607       607/607
(100 %)
11 diff
(98.2 %id)
CK005479 brain/CNS, Human Brain - Frontal Cortex .c 3237 to 3878 1 to 641       641/642
(99 %)
4 diff
(99.4 %id)
CB131343 Liver .c 3254 to 3701 1 to 449       449/449
(100 %)
5 diff
(98.9 %id)
AL525260 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .c 3255 to 4217 1 to 941       941/955
(98 %)
42 diff
(95.7 %id)
AA148128 colon, tumor .c 3277 to 3837 1 to 572       572/576
(99 %)
18 diff
(96.9 %id)
TI_151797163   .c 3328 to 3974 108 to 755     Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 648/649
(99 %)
12 diff
(98.2 %id)
BF573629 melanotic melanoma, high MDR, skin .c 3362 to 4103 1 to 729       729/729
(100 %)
18 diff
(97.6 %id)
DT219890 brain .c 3363 to 4005 1 to 643       643/643
(100 %)
4 diff
(99.4 %id)
CB216038 normal endometrium, late proliferativephase, cycle day 13, uterus .c 3430 to 4049 1 to 620       620/620
(100 %)
1 diff
(99.9 %id)
FN095114 breast carcinoma .c 3432 to 3510 1 to 78       78/79
(98 %)
2 diff
(97.5 %id)
BM804985 ovary (pool of 3) .c 3455 to 4304 7 to 861   tiling clone, AAA   855/861
(99 %)
6 diff
(99.4 %id)
AA459780   .c 3524 to 3836 1 to 314       314/314
(100 %)
7 diff
(97.8 %id)
BX100212   .c 3525 to 4031 1 to 507       507/515
(98 %)
2 diff
(99.7 %id)
BG118925 adenocarcinoma, cell line, Liver .c 3602 to 4350 1 to 734       734/960
(76 %)
29 diff
(97.0 %id)
DA512054 brain .c 3610 to 4167 2 to 559   capped   558/558
(100 %)
2 diff
(99.7 %id)
AI000344 Kidney .c 3623 to 3991 1 to 369     Submitted on the opposite strand 369/369
(100 %)
2 diff
(99.5 %id)
CK024009 brain/CNS, Human Brain - Frontal Cortex .c 3690 to 4207 24 to 540       517/685
(75 %)
6 diff
(99.2 %id)
BX463992 brain, fetal brain .c 3721 to 4725 999 to 1       999/1049
(95 %)
9 diff
(99.2 %id)
TI_154136961   .c 3785 to 4632 930 to 94   AAA   837/1091
(76 %)
27 diff
(97.6 %id)
CB250396 Human Lung Epithelial cells, lung .c 3879 to 4610 750 to 19   AAA   732/737
(99 %)
3 diff
(99.6 %id)
TI_149305402   .c 3885 to 4756 949 to 83   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 867/960
(90 %)
10 diff
(99.0 %id)
FN052612 breast carcinoma .c 3951 to 4003 54 to 3     Submitted on the opposite strand 52/55
(94 %)
0 diff
(100 %id)
BQ225769 melanotic melanoma, skin .c 3974 to 4741 1 to 770       770/773
(99 %)
16 diff
(98.0 %id)
BF530893 anaplastic oligodendroglioma with 1p/19qloss, brain .c 3976 to 4671 1 to 680       680/923
(73 %)
15 diff
(98.4 %id)
BQ006272 Chondrosarcoma, Left Pelvis .c 3976 to 4618 661 to 19   AAA   643/643
(100 %)
1 diff
(99.9 %id)
BU633621 cell lines, Chondrosarcoma .c 3994 to 4743 767 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 749/749
(100 %)
1 diff
(99.9 %id)
BQ336269 marrow .c 4032 to 4410 1 to 379       379/380
(99 %)
21 diff
(94.5 %id)
BE218204 carcinoid, lung .c 4057 to 4630 576 to 3       574/576
(99 %)
0 diff
(100 %id)
BQ004369 Chondrosarcoma, Left Pelvis .c 4058 to 4756 717 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 699/699
(100 %)
2 diff
(99.8 %id)
BP425009 small intestine .c 4069 to 4612 1 to 548     Submitted on the opposite strand 548/548
(100 %)
4 diff
(99.3 %id)
TI_151711145   .c 4069 to 4743 784 to 106   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 679/980
(69 %)
11 diff
(98.9 %id)
BU685759 lung, Primary Lung Epithelial Cells .c 4072 to 4756 703 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 685/685
(100 %)
0 diff
(100 %id)
AW044572 pooled .c 4081 to 4499 424 to 6       419/424
(98 %)
0 diff
(100 %id)
AI278493 placenta .c 4083 to 4499 422 to 6       417/422
(98 %)
0 diff
(100 %id)
BX455371 brain, fetal brain .c 4125 to 4754 633 to 1       633/927
(68 %)
0 diff
(100 %id)
DB531498 hippocampus .c 4134 to 4578 1 to 445     Submitted on the opposite strand 445/445
(100 %)
0 diff
(100 %id)
AA715406 Ewing's sarcoma .c 4142 to 4585 27 to 469       443/469
(94 %)
6 diff
(98.8 %id)
CX868110 embryonic stem .c 4153 to 4756 629 to 26   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 604/604
(100 %)
3 diff
(99.6 %id)
R67264 whole brain .c 4171 to 4514 363 to 12   AAA   352/387
(90 %)
10 diff
(97.5 %id)
AA532794 colon .c 4195 to 4743 543 to 1       543/546
(99 %)
13 diff
(97.7 %id)
BP431460   .c 4199 to 4561 1 to 363       363/363
(100 %)
3 diff
(99.2 %id)
H88014 cochlea, ear .c 4200 to 4584 1 to 392   fully sequenced,   392/392
(100 %)
10 diff
(97.5 %id)
BE217875 carcinoid, lung .c 4200 to 4755 556 to 1       556/556
(100 %)
0 diff
(100 %id)
AU148495   .c 4210 to 4743 534 to 1       534/536
(99 %)
4 diff
(99.3 %id)
DB363009   .c 4210 to 4743 535 to 1       535/539
(99 %)
11 diff
(98.0 %id)
AW975420   .c 4222 to 4742 633 to 113     Submitted on the opposite strand 521/633
(82 %)
0 diff
(100 %id)
AI357294 lymph node, lymphoma, follicular mixed small and largecell .c 4234 to 4620 392 to 7       386/392
(98 %)
0 diff
(100 %id)
BE672116 pooled germ cell tumors .c 4246 to 4744 498 to 1       498/498
(100 %)
2 diff
(99.6 %id)
BF589090 pooled .c 4246 to 4743 498 to 1       498/498
(100 %)
0 diff
(100 %id)
H42140 breast .c 4249 to 4720 473 to 1       473/473
(100 %)
5 diff
(99.0 %id)
BG054817 brain, glioblastoma (pooled) .c 4254 to 4738 485 to 1       485/485
(100 %)
2 diff
(99.6 %id)
AI962598 pooled germ cell tumors .c 4255 to 4756 501 to 1       501/501
(100 %)
5 diff
(99.1 %id)
DB522089 testis .c 4258 to 4743 1 to 486     Submitted on the opposite strand 486/486
(100 %)
0 diff
(100 %id)
N50679 multiple sclerosis lesions .c 4260 to 4632 378 to 1       378/419
(90 %)
7 diff
(98.4 %id)
AI651124 pooled germ cell tumors .c 4266 to 4744 479 to 1       479/479
(100 %)
0 diff
(100 %id)
AI638839 pooled germ cell tumors .c 4273 to 4746 474 to 1       474/474
(100 %)
0 diff
(100 %id)
AI916089 colon, colon tumor, RER+ .c 4273 to 4613 341 to 1       341/341
(100 %)
5 diff
(98.6 %id)
AI917496 pooled germ cell tumors .c 4275 to 4746 476 to 5       472/476
(99 %)
0 diff
(100 %id)
AI627503 Kidney .c 4275 to 4756 482 to 1       482/482
(100 %)
0 diff
(100 %id)
AI492907 Kidney .c 4277 to 4743 467 to 1       467/467
(100 %)
0 diff
(100 %id)
AW615123 pooled germ cell tumors .c 4278 to 4619 342 to 1       342/342
(100 %)
0 diff
(100 %id)
BG403423 bladder, transitional cell papilloma, cell line .c 4282 to 4742 1 to 456   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 456/456
(100 %)
7 diff
(98.5 %id)
DB374029 placenta .c 4282 to 4756 475 to 1       475/480
(98 %)
0 diff
(100 %id)
BF448961 sympathetic trunk .c 4285 to 4634 353 to 4       350/353
(99 %)
0 diff
(100 %id)
AL562510 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .c 4329 to 4714 387 to 1       387/477
(81 %)
7 diff
(98.6 %id)
H88237 cochlea, ear .c 4350 to 4588 240 to 1   fully sequenced,   240/240
(100 %)
0 diff
(100 %id)
R39232 whole brain .c 4367 to 4746 390 to 6       385/390
(98 %)
0 diff
(100 %id)
BE766470 nervous_tumor .c 4371 to 4599 1 to 229       229/231
(99 %)
1 diff
(99.6 %id)
R43669 whole brain .c 4387 to 4756 389 to 13   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 377/428
(88 %)
9 diff
(97.9 %id)
FN109456 breast carcinoma .c 4397 to 4466 69 to 1     Submitted on the opposite strand 69/70
(98 %)
1 diff
(98.6 %id)
F10757 brain, total brain .c 4406 to 4727 322 to 1       322/322
(100 %)
0 diff
(100 %id)
R38287 whole brain .c 4406 to 4756 367 to 11   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 357/386
(92 %)
13 diff
(96.7 %id)
F10878 brain, total brain .c 4444 to 4756 313 to 1       313/313
(100 %)
0 diff
(100 %id)
AI535693 Prostate .c 4449 to 4617 30 to 198   AAA Submitted on the opposite strand 169/198
(85 %)
4 diff
(98.0 %id)
AI535716 Prostate .c 4449 to 4617 30 to 198   AAA Submitted on the opposite strand 169/198
(85 %)
4 diff
(98.0 %id)
AI535755 Prostate .c 4449 to 4617 30 to 198   AAA Submitted on the opposite strand 169/198
(85 %)
4 diff
(98.0 %id)
Z40225 brain, total brain .c 4450 to 4727 278 to 1       278/278
(100 %)
0 diff
(100 %id)
F10321 brain, total brain .c 4451 to 4756 306 to 1       306/306
(100 %)
0 diff
(100 %id)
AA459657   .c 4451 to 4756 306 to 1       306/306
(100 %)
0 diff
(100 %id)
AA195374.
matches multiple genes
mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 4453 to 4618 166 to 1     also hits gene COMMD10 166/176
(94 %)
4 diff
(97.8 %id)
AI394427 pooled .c 4453 to 4638 186 to 1       186/186
(100 %)
3 diff
(98.4 %id)
FN089157 breast carcinoma .c 4465 to 4547 1 to 82       82/82
(100 %)
4 diff
(95.2 %id)
AK299063   .d 1 to 979 1 to 979 exact tiling clone,   979/979
(100 %)
2 diff
(99.8 %id)
DC369517   .d 1 to 565 1 to 565       565/565
(100 %)
0 diff
(100 %id)
BX108423 liver and spleen .e 1 to 461 461 to 1     Submitted on the opposite strand 461/469
(98 %)
4 diff
(99.2 %id)
N91071 liver and spleen .e 1 to 460 463 to 1     Submitted on the opposite strand 463/489
(94 %)
6 diff
(98.8 %id)
AI084981 liver and spleen .e 4 to 390 1 to 385   tiling clone, Submitted on the opposite strand 385/385
(100 %)
4 diff
(99.0 %id)
R00854 liver and spleen .e 6 to 354 1 to 364     Submitted on the opposite strand 364/403
(90 %)
15 diff
(96.3 %id)
N59771 liver and spleen .e 8 to 461 1 to 454     Submitted on the opposite strand 454/486
(93 %)
8 diff
(98.4 %id)
N63664 liver and spleen .e 8 to 435 1 to 430     Submitted on the opposite strand 430/432
(99 %)
7 diff
(98.4 %id)
N78232 liver and spleen .e 13 to 460 455 to 4     Submitted on the opposite strand 452/486
(93 %)
0 diff
(100 %id)
DB257415 uterus .e 31 to 605 2 to 576   tiling clone, capped   575/575
(100 %)
0 diff
(100 %id)
AK026359 human small intestine .e 405 to 1843 1 to 1439 exact tiling clone, available from FLJ, AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 1439/1439
(100 %)
1 diff
(100.0 %id)
AA779340 liver and spleen .e 1004 to 1475 471 to 1       471/471
(100 %)
2 diff
(99.6 %id)
BQ309373 breast .e 1201 to 1393 209 to 10       200/219
(91 %)
0 diff
(100 %id)
BQ309421 breast .e 1201 to 1393 209 to 10       200/219
(91 %)
0 diff
(100 %id)
BQ309359 breast .e 1219 to 1420 1 to 201       201/201
(100 %)
6 diff
(97.1 %id)
BQ309420 breast .e 1219 to 1420 1 to 201       201/201
(100 %)
6 diff
(97.1 %id)
BM672632 eye, eye anterior segment .e 1258 to 1516 276 to 18       259/276
(93 %)
0 diff
(100 %id)
BX097891 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .e 1398 to 1845 462 to 15   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 448/448
(100 %)
0 diff
(100 %id)
AI867036 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .e 1440 to 1846 407 to 1       407/407
(100 %)
0 diff
(100 %id)
AW082603 colon, moderately differentiated adenocarcinoma .e 1490 to 1846 357 to 1       357/357
(100 %)
0 diff
(100 %id)
BF062095 pooled germ cell tumors .e 1530 to 1845 316 to 1       316/316
(100 %)
2 diff
(99.4 %id)
BF222819 pooled germ cell tumors .e 1530 to 1845 316 to 1       316/316
(100 %)
1 diff
(99.7 %id)
AW204438   .e 1635 to 1850 233 to 18   tiling clone, AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 216/216
(100 %)
2 diff
(99.1 %id)
TI_153956931   .f 1 to 841 68 to 900 P74S tiling clone,   833/907
(91 %)
47 diff
(94.9 %id)
BG718982 testis .g 1 to 581 1 to 587   tiling clone, available from MGC,   587/706
(83 %)
19 diff
(97.4 %id)
BC039118 testis .g 6 to 4828 1 to 4823 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 4823/4823
(100 %)
2 diff
(100.0 %id)
DA511479 brain .g 638 to 1217 2 to 581   capped   580/580
(100 %)
1 diff
(99.9 %id)
CB053813 leiomyosarcoma, soft tissue .g 3241 to 3689 10 to 459       450/459
(98 %)
6 diff
(98.7 %id)
DB539522 hippocampus .g 4400 to 4854 1 to 455     Submitted on the opposite strand 455/457
(99 %)
7 diff
(98.5 %id)
BF940943 brain, oligodendroglioma .g 4417 to 4844 427 to 1       427/427
(100 %)
1 diff
(99.8 %id)
AI884823 anaplastic oligodendroglioma, brain .g 4418 to 4857 452 to 13   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 440/440
(100 %)
3 diff
(99.4 %id)
AA620939   .g 4421 to 4847 427 to 1       427/427
(100 %)
0 diff
(100 %id)
AI656068 pooled germ cell tumors .g 4423 to 4837 424 to 8       417/424
(98 %)
0 diff
(100 %id)
AI128954 senescent fibroblast .g 4431 to 4863 434 to 2       433/434
(99 %)
0 diff
(100 %id)
AW025741 pooled germ cell tumors .g 4431 to 4857 428 to 1       428/428
(100 %)
1 diff
(99.8 %id)
AW874186 follicular carcinoma, thyroid .g 4438 to 4846 414 to 1       414/414
(100 %)
6 diff
(98.6 %id)
N22099 cochlea, ear .g 4443 to 4857 430 to 11   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 420/420
(100 %)
5 diff
(98.9 %id)
AW068974 bone marrow stroma .g 4446 to 4844 416 to 18   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 399/399
(100 %)
0 diff
(100 %id)
AA653116   .g 4448 to 4847 404 to 5       400/404
(99 %)
0 diff
(100 %id)
AI699974 pooled germ cell tumors .g 4463 to 4847 390 to 5       386/390
(98 %)
0 diff
(100 %id)
AW090657 brain, tumor, 5 pooled (see description) .g 4483 to 4847 365 to 1       365/365
(100 %)
0 diff
(100 %id)
AW013889   .g 4483 to 4857 393 to 18   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 376/376
(100 %)
3 diff
(99.3 %id)
AI942237 Kidney .g 4484 to 4856 385 to 13   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 373/373
(100 %)
4 diff
(99.0 %id)
AA508523 Prostate .g 4499 to 4843 1 to 345       345/345
(100 %)
4 diff
(98.9 %id)
AA522643 metastatic prostate bone lesion .g 4560 to 4858 9 to 307       299/330
(90 %)
5 diff
(98.5 %id)
AI627488 Kidney .g 4564 to 4858 296 to 2       295/296
(99 %)
0 diff
(100 %id)
BE005150 breast_normal .g 4574 to 4764 9 to 197       189/201
(94 %)
6 diff
(97.1 %id)
C00121   .g 4579 to 4833 1 to 256       256/295
(86 %)
6 diff
(98.0 %id)
AW271758 Kidney .g 4600 to 4857 268 to 11   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 258/258
(100 %)
1 diff
(99.7 %id)
AI024932   .g 4687 to 5157 472 to 1       472/472
(100 %)
1 diff
(99.8 %id)
AI439917 lymph node, lymphoma, follicular mixed small and largecell .g 4730 to 5174 446 to 2   tiling clone,   445/446
(99 %)
0 diff
(100 %id)
AW264865 lung, two pooled squamous cell carcinomas .g 4731 to 5045 315 to 1       315/315
(100 %)
0 diff
(100 %id)
AI401353 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .g 4732 to 5171 440 to 1       440/440
(100 %)
0 diff
(100 %id)
AI129004 senescent fibroblast .g 4781 to 5159 393 to 16   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 378/380
(99 %)
1 diff
(99.8 %id)
AI241392 liver and spleen .g 4784 to 5158 376 to 3       374/376
(99 %)
0 diff
(100 %id)
CB053812 leiomyosarcoma, soft tissue .g 4885 to 5152 326 to 57   AAA   270/277
(97 %)
0 diff
(100 %id)
AI765774 2 pooled tumors (clear cell type), Kidney .g 4969 to 5161 196 to 4       193/196
(98 %)
0 diff
(100 %id)
DA453930 tongue, tumor tissue .h 1 to 592 2 to 595 exact tiling clone, capped   594/594
(100 %)
2 diff
(99.7 %id)
AW104308 pooled .i 1 to 434 437 to 3 R11A I12H G13R G14R E15G ... tiling clone,   435/437
(99 %)
1 diff
(99.8 %id)
BF832582 head_neck Gene STX6, variant not shown              
BF833064 head_neck Gene STX6, variant not shown              
BF833994 head_neck Gene STX6, variant not shown              
DB296171 bladder Gene STX6, variant not shown              
DA046203 bladder Gene STX6, variant not shown       capped      
DA212312 brain Gene STX6, variant not shown       capped Suspected internal deletion, suspected internal deletion, this clone was ignored    
AV734033 pheochromocytoma Gene STX6, variant not shown         This clone was ignored    
BJ990758 hepatoblastoma Gene STX6, variant not shown         Suspected internal deletion, this clone was ignored    
BJ990759 hepatoblastoma Gene STX6, variant not shown         Suspected internal deletion, this clone was ignored    
BF674205 Prostate Gene STX6, variant not shown         Suspected internal deletion, suspected internal deletion, this clone was ignored    
BG480801 choriocarcinoma, placenta Gene STX6, variant not shown         Suspected internal deletion, this clone was ignored    
DA649957   Gene STX6, variant not shown       capped This clone was ignored    
DA711703   Gene STX6, variant not shown       capped Suspected internal deletion, suspected internal deletion, this clone was ignored    
DA744385   Gene STX6, variant not shown       capped This clone was ignored    
DA807660 brain Gene STX6, variant not shown       capped Suspected internal deletion, this clone was ignored    
DB004458 breast, tumor tissue Gene STX6, variant not shown       capped Suspected internal deletion, this clone was ignored    
BM675536 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid Gene STX6, variant not shown         Suspected internal deletion, this clone was ignored    
BM931734 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid Gene STX6, variant not shown       AAA Suspected internal deletion, this clone was ignored    
BM675695 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid Gene STX6, variant not shown         Suspected internal deletion, this clone was ignored    
BM931670 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid Gene STX6, variant not shown       AAA Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI